Search results
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expect
Guru Focus· 4 days agoIts top-selling products include the pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis, with international sales comprising nearly ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 2 days agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed...Massachusetts-based ...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 3 days agoThe revenue decline, as expected, was due to a steep drop in revenues from its COVID-19 products,...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 3 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 3 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 3 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 2 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID< ...
Here's Why Pfizer (PFE) is a Strong Momentum Stock
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) New York-based Pfizer markets a wide range of drugs and vaccines. Pfizer’s Biopharma reporting segment ...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 2 days agoPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically ...